Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 432Neoplasms 371Prostatic Neoplasms 205Lung Neoplasms 191Colorectal Neoplasms 153Motor Activity 94Uterine Cervical Neoplasms 81Pancreatic Neoplasms 78Head and Neck Neoplasms 75Carcinoma, Non-Small-Cell Lung 72Brain Neoplasms 71Ovarian Neoplasms 65Carcinoma, Hepatocellular 54Colonic Neoplasms 50Rectal Neoplasms 49Neoplasm Metastasis 48Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Glioblastoma 44Hematologic Neoplasms 41Depression 41Glioma 37Disease 37Melanoma 36Sarcoma 35Multiple Myeloma 35Stomach Neoplasms 34Carcinoma, Renal Cell 32Pain 31Urinary Bladder Neoplasms 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Dihydropyrimidine Dehydrogenase Deficiency × 90 days × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡